Arcus Capital Partners’s Medtronic MDT Stock Holding History

Arcus Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,169	Closed	-$90.9K	–	248
2022 Q4	$90.9K	Buy	+1,169	New	+$94.7K	0.04%	144
2018 Q3	–	Sell	-3,249	Closed	-$278K	–	110
2018 Q2	$278K	Sell	3,249 -980	-23%	-$81.9K	0.14%	82
2018 Q1	$339K	Buy	4,229 +751	+22%	+$61.9K	0.19%	69
2017 Q4	$281K	Buy	3,478 +229	+7%	+$18.3K	0.16%	89
2017 Q3	$253K	Hold	3,249	–	–	0.13%	94
2017 Q2	$288K	Buy	3,249 +25	+0.8%	+$2.11K	0.18%	79
2017 Q1	$260K	Hold	3,224	–	–	0.16%	87
2016 Q4	$230K	Hold	3,224	–	–	0.16%	86
2016 Q3	$279K	Hold	3,224	–	–	0.2%	55
2016 Q2	$280K	Hold	3,224	–	–	0.27%	49
2016 Q1	$242K	Hold	3,224	–	–	0.17%	54
2015 Q4	$248K	Buy	+3,224	New	+$243K	0.18%	56

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arcus Capital Partners's MDT Position: Q1 2023 in Review

Arcus Capital Partners sold out of Medtronic (MDT) in Q1 2023, closing a stake of 1,169 shares — an estimated $90.9K sold.

Arcus Capital Partners first reported a position in MDT in Q4 2015 and held it in 12 quarters. The position peaked at $339K in Q1 2018. 1,991 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

Arcus Capital Partners reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
Arcus Capital Partners sold 1,169 Medtronic shares in Q1 2023, an estimated $90.9K.
Arcus Capital Partners first reported a position in Medtronic in Q4 2015 and held it in 12 quarters.
Arcus Capital Partners's Medtronic position peaked at $339K in Q1 2018.
1,991 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.